Primary Site >> Biliary tract Cancer
Gene >> MDM2
| 1. | |||||||||||
| Journal: | Virchows Arch. 2000 Jul;437(1):25-30. | ||||||||||
| Title: | Overexpression of MDM2 protein in intrahepatic cholangiocarcinoma: relationship with p53 overexpression, Ki-67 labeling, and clinicopathological features. | ||||||||||
| Author: | Horie, S|Endo, K|Kawasaki, H|Terada, T | ||||||||||
| PMID: | 10963376 | ||||||||||
| 2. | |||||||||||
| Journal: | Diagn Mol Pathol. 2000 Mar;9(1):41-6. | ||||||||||
| Title: | TP53 mutations and mdm2 protein overexpression in cholangiocarcinomas. | ||||||||||
| Author: | Della Torre, G|Pasquini, G|Pilotti, S|Alasio, L|Civelli, E|Cozzi, G|Milella, M|Salvetti, M|Pierotti, M A|Severini, A | ||||||||||
| PMID: | 10718212 | ||||||||||
| 3. | |||||||||||
| Journal: | J Hepatol. 2001 Aug;35(2):235-44. | ||||||||||
| Title: | Microsatellite instability and alternative genetic pathway in intrahepatic cholangiocarcinoma. | ||||||||||
| Author: | Momoi, H|Itoh, T|Nozaki, Y|Arima, Y|Okabe, H|Satoh, S|Toda, Y|Sakai, E|Nakagawara, K|Flemming, P|Yamamoto, M|Shimahara, Y|Yamaoka, Y|Fukumoto, M | ||||||||||
| PMID: | 11580146 | ||||||||||
| 4. | |||||||||||
| Journal: | Hum Pathol. 2004 Dec;35(12):1505-14. | ||||||||||
| Title: | Frequent p16ink4a inactivation is an early and frequent event of intraductal papillary neoplasm of the liver arising in hepatolithiasis. | ||||||||||
| Author: | Ishikawa, Akira|Sasaki, Motoko|Sato, Yasunori|Ohira, Shusaku|Chen, Miin-Fu|Huang, Shiu-Feng|Oda, Koji|Nimura, Yuji|Nakanuma, Yasuni | ||||||||||
| PMID: | 15619210 | ||||||||||
| 5. | |||||||||||
| Journal: | J Clin Oncol. 2006 Mar 1;24(7):1152-60. | ||||||||||
| Title: | Differential cell cycle-regulatory protein expression in biliary tract adenocarcinoma: correlation with anatomic site, pathologic variables, and clinical outcome. | ||||||||||
| Author: | Jarnagin, William R|Klimstra, David S|Hezel, Michael|Gonen, Mithat|Fong, Yuman|Roggin, Kevin|Cymes, Karina|DeMatteo, Ronald P|D'Angelica, Michael|Blumgart, Leslie H|Singh, Bhuvanesh | ||||||||||
| PMID: | 16505435 | ||||||||||
| 6. | |||||||||||
| Journal: | J Gastrointest Surg. 2008 Oct;12(10):1664-72; discussion 1672-3. | ||||||||||
| Title: | Loss of heterozygosity predicts poor survival after resection of pancreatic adenocarcinoma. | ||||||||||
| Author: | Franko, Jan|Krasinskas, Alyssa M|Nikiforova, Marina N|Zarnescu, Narcis O|Lee, Kenneth K W|Hughes, Steven J|Bartlett, David L|Zeh, Herbert J 3rd|Moser, A James | ||||||||||
| PMID: | 18677542 | ||||||||||
| 7. | |||||||||||
| Journal: | Bull Cancer. 2009 Apr;96(4):405-15. | ||||||||||
| Title: | [Prognosis factors of cholangiocarcinoma: contribution of recent molecular biology tools]. | ||||||||||
| Author: | Malouf, G|Dreyer, C|Guedj, N|Paradis, V|Degos, F|Belghiti, J|Le Tourneau, C|Faivre, S|Raymond, E | ||||||||||
| PMID: | 19357015 | ||||||||||
| 8. | |||||||||||
| Journal: | Oncol Lett. 2012 Jul;4(1):101-106. Epub 2012 Apr 17. | ||||||||||
| Title: | Potential genotype-specific single nucleotide polymorphism interaction of common variation in p53 and its negative regulator mdm2 in cholangiocarcinoma susceptibility. | ||||||||||
| Author: | Zimmer, Vincent|Hoblinger, Aksana|Mihalache, Florentina|Assmann, Gunter|Acalovschi, Monica|Lammert, Frank | ||||||||||
| PMID: | 22807971 | ||||||||||
| 9. | |||||||||||
| Journal: | Ann Surg Oncol. 2013 May;20(5):1470-81. | ||||||||||
| Title: | Regional differences in gallbladder cancer pathogenesis: insights from a comparison of cell cycle-regulatory, PI3K, and pro-angiogenic protein expression. | ||||||||||
| Author: | Butte, Jean M|Torres, Javiera|Veras, Emanuela F|Matsuo, Kenichi|Gonen, Mithat|D'Angelica, Michael I|Waugh, Enrique|Meneses, Manuel|Inayama, Yoshiyaki|Fong, Yuman|Dematteo, Ronald P|De La Fuente, Hernan|Endo, Itaru|Klimstra, David S|Jarnagin, William R | ||||||||||
| PMID: | 23212762 | ||||||||||
| 10. | |||||||||||
| Journal: | PLoS One. 2013 Dec 13;8(12):e82426. | ||||||||||
| Title: | Mutation inactivation of Nijmegen breakage syndrome gene (NBS1) in hepatocellular carcinoma and intrahepatic cholangiocarcinoma. | ||||||||||
| Author: | Wang, Yan|Hong, Yu|Li, Man|Long, Jiang|Zhao, Yan-Ping|Zhang, Jun-Xia|Li, Qian|You, Hong|Tong, Wei-Min|Jia, Ji-Dong|Huang, Jian | ||||||||||
| PMID: | 24349281 | ||||||||||
| 11. | |||||||||||
| Journal: | Tumour Biol. 2014 Apr;35(4):3431-8. | ||||||||||
| Title: | MDM2 SNP309 is an ethnicity-dependent risk factor for digestive tract cancers. | ||||||||||
| Author: | Chen, Bo|Cao, Lei|Hu, Kong-Wang|Zhang, Jia-Wei|Meng, Xiang-Ling|Xiong, Mao-Ming | ||||||||||
| PMID: | 24338709 | ||||||||||
| 12. | |||||||||||
| Journal: | PLoS One. 2015 Jul 24;10(7):e0132953. | ||||||||||
| Title: | Cholangiocarcinoma: Correlation between Molecular Profiling and Imaging Phenotypes. | ||||||||||
| Author: | Sadot, Eran|Simpson, Amber L|Do, Richard K G|Gonen, Mithat|Shia, Jinru|Allen, Peter J|D'Angelica, Michael I|DeMatteo, Ronald P|Kingham, T Peter|Jarnagin, William R | ||||||||||
| PMID: | 26207380 | ||||||||||
| 13. | |||||||||||
| Journal: | Drug Des Devel Ther. 2015 Aug 10;9:3969-87. | ||||||||||
| Title: | 20(S)-ginsenoside Rg3 promotes senescence and apoptosis in gallbladder cancer cells via the p53 pathway. | ||||||||||
| Author: | Zhang, Fei|Li, Maolan|Wu, Xiangsong|Hu, Yunping|Cao, Yang|Wang, Xu'an|Xiang, Shanshan|Li, Huaifeng|Jiang, Lin|Tan, Zhujun|Lu, Wei|Weng, Hao|Shu, Yijun|Gong, Wei|Wang, Xuefeng|Zhang, Yong|Shi, Weibin|Dong, Ping|Gu, Jun|Liu, Yingbin | ||||||||||
| PMID: | 26309394 | ||||||||||
| 14. | |||||||||||
| Journal: | J Clin Pathol. 2016 May;69(5):403-8. | ||||||||||
| Title: | Comprehensive genomic profiling of extrahepatic cholangiocarcinoma reveals a long tail of therapeutic targets. | ||||||||||
| Author: | Lee, Hwajeong|Wang, Kai|Johnson, Adrienne|Jones, David M|Ali, Siraj M|Elvin, Julia A|Yelensky, Roman|Lipson, Doron|Miller, Vincent A|Stephens, Philip J|Javle, Milind|Ross, Jeffrey S | ||||||||||
| PMID: | 26500333 | ||||||||||
| 15. | |||||||||||
| Journal: | Pathol Res Pract. 2016 Nov;212(11):1039-1047. | ||||||||||
| Title: | Differentiation and prognostic markers in ampullary cancer: Role of p53, MDM2, CDX2, mucins and cytokeratins. | ||||||||||
| Author: | Perysinakis, Iraklis|Minaidou, Emilia|Mantas, Dimitrios|Sotiropoulos, George C|Leontara, Vasileia|Tsipras, Hercules|Zografos, George N|Margaris, Ilias|Kouraklis, Gregory | ||||||||||
| PMID: | 27688085 | ||||||||||
| 16. | |||||||||||
| Journal: | Am J Surg Pathol. 2018 Apr;42(4):512-521. | ||||||||||
| Title: | MDM2 Amplification in Intrahepatic Cholangiocarcinomas: Its Relationship With Large-Duct Type Morphology and Uncommon KRAS Mutations. | ||||||||||
| Author: | Kim, Sung Joo|Akita, Masayuki|Sung, You-Na|Fujikura, Kohei|Lee, Jae Hoon|Hwang, Shin|Yu, Eunsil|Otani, Kyoko|Hong, Seung-Mo|Zen, Yoh | ||||||||||
| PMID: | 29309301 | ||||||||||
| 17. | |||||||||||
| Journal: | HPB (Oxford). 2018 Aug 28. pii: S1365-182X(18)32708-4. | ||||||||||
| Title: | Histological and molecular characterization of intrahepatic bile duct cancers suggests an expanded definition of perihilar cholangiocarcinoma. | ||||||||||
| Author: | Akita, Masayuki|Sofue, Keitaro|Fujikura, Kohei|Otani, Kyoko|Itoh, Tomoo|Ajiki, Tetsuo|Fukumoto, Takumi|Zen, Yoh | ||||||||||
| PMID: | 30170977 | ||||||||||